|
WO2020210630A1
|
|
Tricyclic degraders of ikaros and aiolos
|
|
WO2020181232A1
|
|
Heterocyclic compounds for medical treatment
|
|
WO2020132561A1
|
|
Targeted protein degradation
|
|
WO2020051235A1
|
|
Compounds for the degradation of brd9 or mth1
|
|
EP3781156A1
|
|
Spirocyclic compounds
|
|
KR20210018199A
|
|
Cerevlon binder for decomposition of Ikaros
|
|
EP3710002A2
|
|
Degraders and degrons for targeted protein degradation
|
|
CN111315735A
|
|
Dihydrobenzimidazolones
|
|
EP3679026A1
|
|
Glutarimide
|
|
CN110769822A
|
|
N/O-linked degron and degron bodies for protein degradation
|
|
CN109790143A
|
|
The C of amine connection for target protein degradation3Glutarimide degron body
|
|
WO2017197056A1
|
|
Bromodomain targeting degronimers for target protein degradation
|
|
CN109641874A
|
|
C for target protein degradation3The glutarimide degron body of carbon connection
|
|
WO2017197036A1
|
|
Spirocyclic degronimers for target protein degradation
|
|
CN109562107A
|
|
Heterocycle degron body for target protein degradation
|
